|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
types of cancer in 185 countries. CA Cancer J Clin. 71:209–249.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Long AG, Lundsmith ET and Hamilton KE:
Inflammation and colorectal cancer. Curr Colorectal Cancer Rep.
13:341–351. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei X, Zhang Y, Yang Z, Sha Y, Pan Y, Chen
Y and Cai L: Analysis of the role of the interleukins in colon
cancer. Biol Res. 53:202020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamaguchi M, Okamura S, Yamaji T, Iwasaki
M, Tsugane S, Shetty V and Koizumi T: Plasma cytokine levels and
the presence of colorectal cancer. PLoS One. 14:e02136022019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kantola T, Klintrup K, Väyrynen JP,
Vornanen J, Bloigu R, Karhu T, Herzig KH. Näpänkangas J, Mäkelä J,
Karttunen TJ, et al: Stage-dependent alterations of the serum
cytokine pattern in colorectal carcinoma. Br J Cancer.
107:1729–1736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bünger S, Haug U, Kelly M, Posorski N,
Klempt-Giessing K, Cartwright A, Fitzgerald SP, Toner V, McAleer D,
Gemoll T, et al: A novel multiplex-protein array for serum
diagnostics of colon cancer: A case-control study. BMC Cancer.
12:3932012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ueda T, Shimada E and Urakawa T: Serum
levels of cytokines in patients with colorectal cancer: Possible
involvement of interleukin-6 and interleukin-8 in hematogenous
metastasis. J Gastroenterol. 29:423–429. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
R Core Team R, . A language and
environment for statistical computing. R foundation for statistical
computing; Vienna: 2021, https://www.r-project.org/
|
|
9
|
Chung YC and Chang YF: Serum interleukin-6
levels reflect the disease status of colorectal cancer. J Surg
Oncol. 83:222–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan G, Liu T, Yin L, Kang Z and Wang L:
Levels of peripheral Th17 cells and serum Th17-related cytokines in
patients with colorectal cancer: A meta-analysis. Cell Mol Biol
(Noisy-le-grand). 64:94–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu J, Ye Y, Zhang H, Szmitkowski M,
Mäkinen MJ, Li P, Xia D, Yang J, Wu Y and Wu H: Diagnostic and
prognostic value of serum interleukin-6 in colorectal cancer.
Medicine (Baltimore). 95:e25022016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Doulabi H, Rastin M, Shabahangh H, Maddah
G, Abdollahi A, Nosratabadi R, Esmaeili SA and Mahmoudi M: Analysis
of Th22, Th17 and CD4+ cells co-producing IL-17/IL-22 at
different stages of human colon cancer. Biomed Pharmacother.
103:1101–1106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stanilov N, Miteva L, Deliysky T, Jovchev
J and Stanilova S: Advanced colorectal cancer is associated with
enhanced IL-23 and IL-10 serum levels. Lab Med. 41:159–163. 2010.
View Article : Google Scholar
|
|
14
|
Karabulut S, Usul Afsar C, Karabulut M,
Kilic L, Alis H, Kones O, Bilgin E and Faruk Aykan N: Clinical
significance of serum interleukin-17 levels in colorectal cancer
patients. J Buon. 21:1137–1145. 2016.PubMed/NCBI
|
|
15
|
Wägsäter D, Löfgren S, Hugander A and
Dimberg J: Expression of interleukin-17 in human colorectal cancer.
Anticancer Res. 26:4213–4216. 2006.PubMed/NCBI
|
|
16
|
Li B, Wang F, Ma C, Hao T, Geng L and
Jiang H: Predictive value of IL-18 and IL-10 in the prognosis of
patients with colorectal cancer. Oncol Lett. 18:713–719.
2019.PubMed/NCBI
|
|
17
|
Abtahi S, Davani F, Mojtahedi Z, Hosseini
SV, Bananzadeh A and Ghaderi A: Dual association of serum
interleukin-10 levels with colorectal cancer. J Cancer Res Ther.
13:252–256. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alexiou D, Karayiannakis AJ, Syrigos KN,
Zbar A, Kremmyda A, Bramis I and Tsigris C: Serum levels of
E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients:
Correlations with clinico-pathological features, patient survival
and tumour surgery. Eur J Cancer. 37:2392–2397. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Korniluk A, Kamińska J, Kiszło P, Kemona H
and Dymicka-Piekarska V: Lectin adhesion proteins (P-, L- and
E-selectins) as biomarkers in colorectal cancer. Biomarkers.
22:629–634. 2017.PubMed/NCBI
|
|
20
|
Polistena A, Cucina A, Dinicola S, Stene
C, Cavallaro G, Ciardi A, Orlando G, Arena R, D'Ermo G, Cavallaro
A, et al: MMP7 expression in colorectal tumours of different
stages. In Vivo. 28:105–110. 2014.PubMed/NCBI
|
|
21
|
Peeters C, Ruers T, Westphal J and de Waal
RMW: Progressive loss of endothelial P-selectin expression with
increasing malignancy in colorectal cancer. Lab Invest. 85:248–256.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shibata M, Ando K, Amano S and Kurosu Y:
Local expression and circulating form of ICAM-1 in colorectal
cancer. Ann Cancer Res Ther. 5:29–33. 1996. View Article : Google Scholar
|
|
23
|
Pengjun Z, Xinyu W, Feng G, Xinxin D,
Yulan L, Juan L, Xingwang J, Zhennan D and Yaping T: Multiplexed
cytokine profiling of serum for detection of colorectal cancer.
Future Oncol. 9:1017–1027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang D, Yuan W, Wang Y, Wu Q, Yang L, Li
F, Chen X, Zhang Z, Yu W, Maimela NR, et al: Serum CCL20 combined
with IL-17A as early diagnostic and prognostic biomarkers for human
colorectal cancer. J Transl Med. 17:2532019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karpinski P, Rossowska J and Sasiadek MM:
Immunological landscape of consensus clusters in colorectal cancer.
Oncotarget. 8:105299–105311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mager LF, Wasmer MH, Rau TT and Krebs P:
Cytokine-induced modulation of colorectal cancer. Front Oncol.
6:962016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ramdzan AR, Abd Rahim MA, Mohamad Zaki A,
Zaidun Z and Mohammed Nawi A: Diagnostic accuracy of FOBT and
colorectal cancer genetic testing: A systematic review &
meta-analysis. Ann Glob Health. 85:702019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang M, Cen X, Xie Q, Zuo C, Shi G and Yin
G: Serum interleukin-6 expression level and its clinical
significance in patients with dermatomyositis. Clin Dev Immunol.
2013:7178082013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pavlovic V, Dimic A, Milenkovic S and
Krtinic D: Serum levels of IL-17, IL-4 and IFNγ in Serbian patients
with early rheumatoid arthritis. J Res Med Sci. 19:18–22.
2014.PubMed/NCBI
|
|
30
|
Jafarzadeh A, Mahdavi R, Jamali M,
Hajghani H, Nemati M and Ebrahimi HA: Increased concentrations of
interleukin-33 in the serum and cerebrospinal fluid of patients
with multiple sclerosis. Oman Med J. 31:40–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Palucka AK and Coussens LM: The basis of
oncoimmunology. Cell. 164:1233–1247. 2016. View Article : Google Scholar : PubMed/NCBI
|
